1. Home
  2. TECH vs ACI Comparison

TECH vs ACI Comparison

Compare TECH & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • ACI
  • Stock Information
  • Founded
  • TECH 1976
  • ACI 1860
  • Country
  • TECH United States
  • ACI United States
  • Employees
  • TECH N/A
  • ACI N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • ACI Food Chains
  • Sector
  • TECH Health Care
  • ACI Consumer Staples
  • Exchange
  • TECH Nasdaq
  • ACI Nasdaq
  • Market Cap
  • TECH 11.3B
  • ACI 11.0B
  • IPO Year
  • TECH 1989
  • ACI 2020
  • Fundamental
  • Price
  • TECH $73.17
  • ACI $19.50
  • Analyst Decision
  • TECH Buy
  • ACI Buy
  • Analyst Count
  • TECH 8
  • ACI 11
  • Target Price
  • TECH $82.00
  • ACI $23.11
  • AVG Volume (30 Days)
  • TECH 795.5K
  • ACI 6.8M
  • Earning Date
  • TECH 01-30-2025
  • ACI 01-07-2025
  • Dividend Yield
  • TECH 0.44%
  • ACI 2.46%
  • EPS Growth
  • TECH N/A
  • ACI N/A
  • EPS
  • TECH 0.95
  • ACI 1.71
  • Revenue
  • TECH $1,171,583,000.00
  • ACI $79,713,700,000.00
  • Revenue This Year
  • TECH $7.67
  • ACI $2.47
  • Revenue Next Year
  • TECH $9.38
  • ACI $2.05
  • P/E Ratio
  • TECH $77.07
  • ACI $11.42
  • Revenue Growth
  • TECH 2.41
  • ACI 1.21
  • 52 Week Low
  • TECH $61.16
  • ACI $17.00
  • 52 Week High
  • TECH $85.57
  • ACI $23.47
  • Technical
  • Relative Strength Index (RSI)
  • TECH 46.90
  • ACI 54.44
  • Support Level
  • TECH $69.48
  • ACI $18.75
  • Resistance Level
  • TECH $77.62
  • ACI $20.08
  • Average True Range (ATR)
  • TECH 2.45
  • ACI 0.73
  • MACD
  • TECH -0.45
  • ACI 0.02
  • Stochastic Oscillator
  • TECH 41.28
  • ACI 81.17

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About ACI Albertsons Companies Inc.

Albertsons is the second largest supermarket operator in the United States with over 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.

Share on Social Networks: